Xiao-Jing Wang, MD, PhD, assumed the role of Chief Science Officer and Associate Director for Basic Science for the UC Davis Comprehensive Cancer Center in Davis, California. She is also Associate Director for Basic Science.
Dr. Wang comes to UC Davis from the University of Colorado Anschutz Medical Campus, where she was a tenured full Professor, holding joint appointments in the Departments of Pathology, Dermatology, Otolaryngology, Radiation Oncology, and Craniofacial Biology. She was also the John. S. Gates Endowed Chair of Cancer Stem Cell Biology, as well as Founding Director of Head and Neck Cancer Research Program, Director of T32 Training Program of Lung, Head and Neck Cancer, and Co-Director of the Colorado Head and Neck SPORE Program.
Xiao-Jing Wang, MD, PhD
Primo “Lucky” Lara, Jr, MD
“Our research innovations and areas will broaden significantly with our appointment of Dr. Wang,” said UC Davis Comprehensive Cancer Center Director Primo “Lucky” Lara, Jr, MD. “She brings to UC Davis not only a portion of the Head and Neck SPORE funding, but true programmatic collaborations as well, with its exciting advancements of science leading to novel therapies for multiple cancer types.”
“UC Davis Comprehensive Cancer Center’s reputation as a research institution is growing internationally and I’m humbled to join the institution at its rapidly growing phase with my significant efforts in developing team science, clinical translation, and training/mentoring and innovation,” Dr. Wang said.
Dr. Wang obtained her medical degree and doctorate in neuroscience from Beijing Medical University in China and completed her postdoctoral education at The University of Texas MD Anderson Cancer Center in Houston. Her independent research career started at Baylor College of Medicine in Houston as a tenured Associate Professor and then moved to Oregon Health & Science University as a tenured full Professor before joining the University of Colorado.
